Literature DB >> 6275870

Pyrophosphate heart scan in patients with progressive systemic sclerosis.

F Duska, P Bradna, J Novák, J Kubícek, J Vizda, P Kafka, Y Mazurová, V Blaha.   

Abstract

Scintigraphic examination of the myocardium, using 99mTc-labelled pyrophosphate, was carried out in 17 patients suffering from systemic sclerosis. This connective tissue disorder very often affects the myocardium secondarily. The results of the cardiac scan were compared with the information obtained from the electrocardiogram of systolic time intervals. In addition, spirometry was undertaken to detect a potential relation between cardiac and pulmonary involvement. The scan was found to be positive in seven patients and electrocardiographic findings were pathological in five patients only. The systolic time intervals were abnormal in three patients only. A ventilation disturbance was recorded in 10 patients. No clear relation was found between the results of the individual examinations. It is concluded that pyrophosphate heart scintigraphy may detect myocardial impairment in some cases of systemic sclerosis before it is manifested by heart failure. Examination of systolic time intervals is of little importance.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6275870      PMCID: PMC481101          DOI: 10.1136/hrt.47.1.90

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  7 in total

1.  Technetium-99m stannous pyrophosphate scintigraphy in patients with calcification within the cardiac silhouette.

Authors:  R W Wald; L Sternberg; V F Huckell; H M Staniloff; D H Feiglin; J E Morch
Journal:  Br Heart J       Date:  1978-05

2.  A new method for radionuclide imaging of acute myocardial infarction in humans.

Authors:  R W Parkey; F J Bonte; S L Meyer; J M Atkins; G L Curry; E M Stokely; J T Willerson
Journal:  Circulation       Date:  1974-09       Impact factor: 29.690

3.  Localization of myocardial disorders other than infarction with 99mTc-labeled phosphate agents.

Authors:  L A Perez; D B Hayt; L M Freeman
Journal:  J Nucl Med       Date:  1976-04       Impact factor: 10.057

4.  The sensitivity of scintigraphic myocardial imaging by the use of 99mTc-labelled pyrophosphate in the diagnosis of cardiomyopathy of various etiology.

Authors:  F Duska; J Vizda; J Kubícek; P Kafka; Z Nesvadba; P Zdánský; J Bastecký
Journal:  Eur J Nucl Med       Date:  1979-04-01

5.  Positive myocardial scintigraphy at the bedside--evaluation using a portable gamma camera.

Authors:  D S Dymond; P H Jarritt; K E Britton; D Langley; R A Spurrell
Journal:  Postgrad Med J       Date:  1978-10       Impact factor: 2.401

6.  Technetium-99m stannous pyrophosphate myocardial scintigraphy after cardiopulmonary resuscitation with cardioversion.

Authors:  R Davison; S M Spies; J Przybylek; H Hai; M Lesch
Journal:  Circulation       Date:  1979-08       Impact factor: 29.690

7.  Pathophysiology of technetium-99m stannous pyrophosphate and thallium-201 scintigraphy of acute anterior myocardial infarcts in dogs.

Authors:  L M Buja; R W Parkey; E M Stokely; F J Bonte; J T Willerson
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

  7 in total
  1 in total

1.  Non-invasive assessment of early cardiac involvement in systemic sclerosis.

Authors:  G S Butrous; P M Dowd; J Milne; D S Dymond; J Caplin; A J Camm
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.